Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs (LAUREL Study)

NCT04628039 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT04628039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04628039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chronic Lung Disease and COVID-19: Understanding Severity, Recovery and Rehabilitation Needs (LAUREL Study)
Lead sponsor
VA Office of Research and Development
Phase
Observational
Overall status
Completed
Start date
May 27, 2021
Completion date
December 31, 2025
Enrollment
622 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic lung diseases, covid-19